跳至主要内容
临床试验/NCT07184957
NCT07184957招募中不适用

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Treatment Complications

研究概览

简要总结

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
  • •Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

排除标准

  • •Men that are not diagnosed with prostate cancer.
  • •Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

研究组 & 干预措施

Men with Prostate Cancer

Men who receive cryotherapy for ablation of clinically localized prostate cancer.

结局指标

主要结局

Treatment Complications

时间窗: Up to Year 15

PSA-Progression Free Survival

时间窗: Up to Year 15

Length of time following cryotherapy for ablation treatment of prostate cancer that a patient lives without their prostate-specific antigen (PSA) levels rising significantly enough to indicate disease recurrence, or without dying from any cause.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验